Minims Natriumfluoresceïne Bausch + Lomb Ireland Limited (Fluorescein Sodium)

Fluorescein Sodium adheres to damaged epithelial cells and, when illuminated with cobalt‑blue light, emits a bright green fluorescence. This fluorescence makes areas of epithelial loss or tear‑film breakup visible, allowing clinicians to quickly identify and evaluate ocular surface pathology.

The dose and frequency are determined by the prescribing eye‑care professional based on the specific diagnostic need. Typically, a single drop is instilled onto the ocular surface, but the exact regimen should follow the clinician’s instructions.

Safety data for Fluorescein Sodium in pregnancy and lactation are limited. It should be used only if clearly indicated and after a risk‑benefit assessment by the health‑care provider. Women who are pregnant or breastfeeding should discuss potential risks with their clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Fluorescein Sodium provides rapid, high‑contrast green fluorescence and is widely used for corneal abrasion detection. Alternatives such as Rose Bengal or Lissamine Green stain damaged cells differently and may cause more irritation. Fluorescein is generally preferred for quick screening because of its ease of use and lower discomfort.

Store the product at ambient temperature, preferably below 25 °C, in its original sealed container. Protect it from direct sunlight and moisture. Avoid freezing, and keep the vial tightly closed when not in use to maintain sterility and fluorescence integrity.

The solution is administered as an ocular drop. The prescriber or trained eye‑care professional instills a single drop onto the conjunctival sac, allowing it to spread across the corneal surface. After a brief waiting period, the eye is examined under cobalt‑blue illumination to assess staining.

Serious risks, though rare, include allergic hypersensitivity reactions such as swelling, itching, or rash, and severe corneal toxicity in eyes with pre‑existing epithelial compromise. Any signs of significant discomfort, vision change, or systemic symptoms should prompt immediate medical evaluation.

Patients with a known allergy to fluorescein or any component of the formulation should avoid use. Individuals with severe ocular surface disease, active infection, or compromised corneal epithelium should only use the product under close supervision of an eye‑care professional.